See more : Strategic Oil & Gas Ltd. (SOGFF) Income Statement Analysis – Financial Results
Complete financial analysis of Research Alliance Corp. II (RACB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Research Alliance Corp. II, a leading company in the Shell Companies industry within the Financial Services sector.
- Waaree Energies Ltd (WAAREEENER.NS) Income Statement Analysis – Financial Results
- Zealand Pharma A/S (ZLDPF) Income Statement Analysis – Financial Results
- The SPAR Group Ltd (SPP.JO) Income Statement Analysis – Financial Results
- Meryllion Resources Corp. (MYR.CN) Income Statement Analysis – Financial Results
- SimiGon Ltd. (SIM.L) Income Statement Analysis – Financial Results
Research Alliance Corp. II (RACB)
About Research Alliance Corp. II
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.
| Metric | 2021 |
|---|---|
| Revenue | 0.00 |
| Cost of Revenue | 467.64K |
| Gross Profit | -467.64K |
| Gross Profit Ratio | 0.00% |
| Research & Development | 0.00 |
| General & Administrative | 467.64K |
| Selling & Marketing | 0.00 |
| SG&A | 467.64K |
| Other Expenses | 0.00 |
| Operating Expenses | 467.64K |
| Cost & Expenses | 467.64K |
| Interest Income | 11.63K |
| Interest Expense | -11.63K |
| Depreciation & Amortization | 11.63K |
| EBITDA | -456.01K |
| EBITDA Ratio | 0.00% |
| Operating Income | -467.64K |
| Operating Income Ratio | 0.00% |
| Total Other Income/Expenses | 11.63K |
| Income Before Tax | -456.01K |
| Income Before Tax Ratio | 0.00% |
| Income Tax Expense | -11.63K |
| Net Income | -444.37K |
| Net Income Ratio | 0.00% |
| EPS | -0.02 |
| EPS Diluted | -0.02 |
| Weighted Avg Shares Out | 19.19M |
| Weighted Avg Shares Out (Dil) | 19.19M |
Research Alliance Corp. II Will Redeem Public Shares
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Research Alliance Corp. I - RACA
Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Closing of $149.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Source: https://incomestatements.info
Category: Stock Reports